We report in this paper that Glycophorin C (GPC) is the receptor for PfEBP-2 (baebl, EBA-140),
Introduction
Invasion of erythrocytes by the malaria parasites is a multi-step process involving several specific interactions between receptors on the red blood cells (RBCs) and parasite ligands 1 .
Inhibition of RBC invasion would prevent infection and consequently disease. Therefore, considerable effort has gone into the identification and characterization of the molecules involved in this process. Plasmodium falciparum is not completely dependent on a single receptor for the invasion of human erythrocytes 2 . This heterogeneity was highlighted by the different invasion rates obtained when distinct strains of the parasite were used to invade enzymatically modified RBCs and RBC mutants [3] [4] [5] [6] . Based on this receptor heterogeneity, the invasion process was divided into three pathways: glycophorin A (GPA) and sialic acid dependent; GPA-independent but sialic acid dependent; and GPA and sialic acid independent but trypsin sensitive. The GPA-independent pathways are referred to as the alternative pathways of invasion 4 . In P. falciparum, only that involving GPA and the 175-kDa erythrocyte-binding antigen (EBA-175 has been well characterized 7 . Recently, PfEBP-2 as well as two additional potential parasite ligands 8 containing the cysteine rich Duffy binding like (DBL) motifs found in EBA-175 7 of P. falciparum and Duffy binding protein-1 in P. vivax 9 were identified from the genome sequencing project, all of which are postulated to have a role in invasion [10] [11] [12] . In this study, we report the identification of glycophorin C (GPC) as a receptor for PfEBP-2 and show that the binding on GPC is limited to aa 14-22 in exon 2.
Materials and Methods
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Antibodies against PfEBP-2
Gene fragments encoding 3 different regions of PfEBP-2 (chr13_4000047.phat_1) 13 were amplified from genomic DNA and expressed as GST fusion polypeptides 14 : EBP-2-1 (aa 333-452 and part of the DBL domain); EBP-2-2 (aa 798-962); and EBP-2-3 (aa 968-1137).
Antibodies were raised against all 3 recombinant proteins in mice (2µg/ immunization/ mouse) using the repetitive immunization schedule 15, 16 and in rabbits (100 µg/immunization using CFA/IFA). All antibodies recognized the native protein similarly, however, all binding studies presented are those done with mouse anti-EBP-2-3.
Parasites
P. falciparum 3D7 strain was grown in culture in human erythrocytes 17 . To obtain biosynthetically labeled secreted parasite proteins, containing the pool of putative binding ligands 6 , parasites were synchronized 18 and the schizonts purified 19 
Erythrocyte binding assay
An aliquot of 500 µl of labeled parasite supernatant, confirmed having PfEBP-2 by immunoprecipitation, was mixed with 100 µl of target erythrocytes for 30 min at RT. The mixture was then spun at 6000 g for 1 min through sodium phthalate, to remove unbound material. RBCs pelleted at the bottom of the tube, along with parasite proteins bound to them, were recovered by puncturing the tube. Cells were lysed in NETT (0.5% Triton X100, 150 mM NaCl, 10 mM EDTA, 50 mM Tris, pH 7.4) for 30 min at 4 o C and spun at 14,000 rpm for 5 min.
The soluble extract containing the PfEBP-2 ligand-receptor complex was immunoprecipitated with mouse antibodies against EBP-2-3. All experiments were repeated at least three times with identical pattern of binding.
Antibody Mediated Inhibition of Binding
The binding specificity of PfEBP-2 to GPC on RBCs was tested by examining the effect of four
MAbs against different regions of GPC 21, 22 : 2B-39 (aa 1-6), 2B-41 (aa 16-22), 3-23 (aa [13] [14] [15] [16] [17] [18] [19] [20] and 2B-42 (aa 45-50) (see Fig. 2A ), along with a control MAb against the Kell antigen (MIMA For personal use only. on . by guest www.bloodjournal.org From 40) on the binding. Each MAb was pre-incubated at 100 µg/ml with normal RBCs for 30 min before 500 µl of parasite supernatant was added and processed as described above. For comparison, mouse anti-EBP-2-3 serum and the pre-immune serum were used to confirm the ability of specific antibodies to block binding of the ligand to the receptor.
RESULTS AND DISCUSSION

Receptor Identity of PfEBP-2
Binding of PfEBP-2 was totally abolished by treatment of normal RBCs with neuraminidase or trypsin ( chymotrypsin and are present on RBC in high copies 20 . Any changes in their presence or their conformational structure after treatment could rearrange the surface topology of the RBC and thus potentially increase the access of the ligand to its specific receptor.
We thus focused our binding studies on RBC surface proteins that are sialylated and sensitive to cleavage by trypsin by using mutant RBCs, deficient in one of a number of such blood group (Fig. 1B) . However, erythrocytes lacking GPC (GPC null, Leach phenotype) did not bind PfEBP-2 at all. These results supported the enzymatic profile of the receptor obtained in Figure 1A as GPC is a membrane sialoglycoprotein which is cleaved by trypsin between residues 48 and 49 20 . The moderate increase of binding to the mutant S-s-U-and K 0 cells (Fig. 1B) could also be due to changes in the ability of the ligand to bind to the GPC receptor as was discussed above. GPB is sensitive to chymotrypsin and therefore the pattern of binding of the S-s-U-cells (GPB null) is in accordance to those of chymotrypsin RBC treated cells.
For Glycophorins have long been postulated to serve as receptors for P. falciparum merozoites 23 .
However, most of the initial studies focused on GPA as the primary receptor and GPB as the secondary one. Although PfEBP-2 binding to human RBCs is dependent on sialic acid, we have clearly shown that it does not bind to either GPA or GPB. Hence, this receptor-ligand interaction involving GPC represents a third sialic acid dependent pathway of invasion.
All P. falciparum members of the DBL-EBP superfamily of proteins are characterized by the presence of 2 cysteine rich domains that are homologous to the binding domain first reported in the DBP of P. vivax 24 . EBA-175 has 2 such domains, F1 and F2 of which the F2 domain was not to Gerbich phenotype cells, which lack just the peptide encoded by exon 3 of GPC. The method used in their study was an indirect way of assaying for PfEBP-2 binding and could be subject to excess residual protein present in the supernatant. Thus, our study is the first to offer direct evidence for a role for GPC in parasite invasion into the red cell.
Characterization of Binding Domains on GPC
To confirm and further characterize the regions of GPC that were responsible for binding PfEBP-2, binding analysis of the 3 naturally occurring variants of GPC 19 : Leach phenotype (GPC null),
Gerbich phenotype (lacking exon 3, aa 36-63) and Yus phenotype (lacking exon 2, aa 14-35) was carried out (Fig. 2C) . The results confirmed that Leach cells do not bind PfEBP-2, Gerbich cells The above results strongly implicate the region between residues 13 and 22 of GPC as the binding domain for PfEBP-2, of which aa 14-22 lie within exon 2. The EBA-175 interaction with GPA was shown to involve both the sialic acid residues and the aa 1-64 peptide backbone of
For personal use only. on . by guest www.bloodjournal.org From Our studies validate the existence of multiple invasion pathways and have identified a new ligand-receptor interaction, PfEBP-2 and GPC. Access to numerous invasion pathways provides redundancy and adaptability to P. falciparum merozoites for this critical step in their life cycle --the parasite has a survival advantage when faced with receptor heterogeneity in humans and/or specific immune responses against a particular parasite ligand. Moreover, RBC polymorphisms seem to have emerged by natural selection, protecting the host from severe malaria infection, as there is a significant geographic overlap between malaria endemicity and RBC disorders 25 . In
Western Pacific, Southeast Asian Ovalocytosis (SAO) is found at high frequency and was thought to afford a survival advantage against malaria. SAO had been associated with a 27 bp deletion in band 3 and also linked to a GPC polymorphism. The Gerbich phenotype in these regions was thought to be associated with the reduced frequency of malaria infections caused by both P. falciparum and P. vivax 26 . However, most recent studies in a population in the same endemic area that was genotyped for a deletion in exon 3 of GPC have found that this polymorphism afforded no significant protection from infection 27 . Our results suggest that polymorphism in exon 2 in addition to that in exon 3 of GPC should be more closely examined in order to find a molecular basis for the selection of GPC variants in these malaria endemic areas. Of note is the fact that no GPA-deficiency polymorphisms have been reported in malaria endemic regions, suggesting that the GPA-EBA-175 interaction may not be the primary route of parasite invasion, although EBA-175 appears to be synthesized at much higher levels than PfEBP-2 (data not shown). On the other hand, other non-malaria selective forces might be responsible for the lack of GPA polymorphism in malaria endemic areas. The importance of elucidating the GPA "alternative" pathways of invasion was recently highlighted by studies on 28 where a majority of strains were reported to use non-GPA mediated pathways of invasion.
Another point of view relating to the existence of multiple invasion pathways is that multiple ligand-receptor interactions have to take place so invasion can occur. Unless appropriate signals from all components of the molecular recognition cascade are in place the parasite cannot enter the RBC. Some proteins may play a role early in the invasion process whereas members of the EBP family, because of their homology to DBP-1 of P. vivax, are postulated to be involved in junction formation 24 . Now that the genome of P. falciparum is completely sequenced 29 
